Advisor
i&i BioCheck size: €150K for company creation and roughly €500K-€2M for initial venture investments, as published by i&i Bio.
Magdalena Marciniak, Ph.D. is listed in a Advisor capacity at i&i Bio. The firm does not publish a person-specific investment mandate for this role; the firm's strategy is included only as shared organizational context.
Validated science, protectable intellectual property, credible translational plans and founders who can move discoveries toward clinical or commercial milestones.
No formal pass list is public. Projects without strong scientific validation, life-science relevance or a feasible development path appear less aligned.
This is not presented as a direct investor role. Use i&i Bio's official fundraising channel and address an investment-team member; the firm's published pitch context is: Present the science, validation, IP, development and regulatory path, team, milestone budget and why i&i Bio's regional network matters.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Magdalena Marciniak, Ph.D. is a current Advisor at i&i Bio. i&i Bio says she has more than ten years across healthcare, biotechnology and consumer goods, specializing in commercialization and strategic partnerships.